The seven centres will aid disease research and clinical development, improving access to patient data for studies.
List view / Grid view
National Health Service (NHS)
Filter the results
The Kymriah (tisagenlecleucel) treatment has received a positive appraisal from the Scottish Medicines Consortium, after EMA approval last year.
The voretigene neparvovec gene therapy treatment has been highlighted in draft guidance by NICE for availability on the NHS.
A statement from 11 health union leaders highlights the possibility of severe drug shortages if the UK leaves the EU without a deal.
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
The NHS is set to launch a new payment method for antibiotic development to incentivise pharmaceutical companies.
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.